1. Home
  2. NVG vs HAE Comparison

NVG vs HAE Comparison

Compare NVG & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen AMT-Free Municipal Credit Income Fund

NVG

Nuveen AMT-Free Municipal Credit Income Fund

HOLD

Current Price

$13.35

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.62

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVG
HAE
Founded
1999
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
NVG
HAE
Price
$13.35
$57.62
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$86.00
AVG Volume (30 Days)
568.8K
1.1M
Earning Date
01-01-0001
02-05-2026
Dividend Yield
4.65%
N/A
EPS Growth
N/A
43.84
EPS
N/A
3.65
Revenue
N/A
$1,318,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.86
P/E Ratio
N/A
$15.78
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$47.32
52 Week High
$12.21
$87.32

Technical Indicators

Market Signals
Indicator
NVG
HAE
Relative Strength Index (RSI) 67.13 23.44
Support Level $13.15 $55.95
Resistance Level $13.59 $60.50
Average True Range (ATR) 0.14 2.35
MACD 0.05 -0.58
Stochastic Oscillator 66.98 15.70

Price Performance

Historical Comparison
NVG
HAE

About NVG Nuveen AMT-Free Municipal Credit Income Fund

Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: